Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Suresh, Muthukumaraswamy"'
Autor:
Dimitri Daldegan-Bueno, Carina Joy Donegan, Anna Forsyth, Rachael Louise Sumner, Robin J. Murphy, David B. Menkes, William Evans, Nicholas Hoeh, Frederick Sundram, Lisa M. Reynolds, Rhys Ponton, Alana Cavadino, Todd Smith, Partha Roop, Nathan Allen, Binu Abeysinghe, Darren Svirskis, Mahima Bansal, Suresh Muthukumaraswamy
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Background Major depressive disorder (MDD) poses a significant global health burden with available treatments limited by inconsistent efficacy and notable side effects. Classic psychedelics, including lysergic acid diethylamide (LSD), have g
Externí odkaz:
https://doaj.org/article/70cd426a594a4075b74f8e1ff6061e30
Autor:
Nathan Allen, Aron Jeremiah, Robin Murphy, Rachael Sumner, Anna Forsyth, Nicholas Hoeh, David B. Menkes, William Evans, Suresh Muthukumaraswamy, Frederick Sundram, Partha Roop
Publikováno v:
Translational Psychiatry, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Microdosing psychedelic drugs at a level below the threshold to induce hallucinations is an increasingly common lifestyle practice. However, the effects of microdosing on sleep have not been previously reported. Here, we report results from
Externí odkaz:
https://doaj.org/article/76f5c7976a2947a4ae5d60b9a3240cd4
Autor:
Alesha Wells, A. P. Suresh Muthukumaraswamy, Eva Morunga, Will Evans, Alana Cavadino, Mahima Bansal, Nicola J. Lawrence, Amanda Ashley, Nicholas R. Hoeh, Frederick Sundram, Allison J. Applebaum, Hineatua Parkinson, Lisa Reynolds
Publikováno v:
Pilot and Feasibility Studies, Vol 10, Iss 1, Pp 1-17 (2024)
Abstract Background An advanced cancer diagnosis can be associated with a significant profile of distress. Psychedelic compounds have shown clinically significant effects in the treatment of psychological distress in patients with advanced-stage canc
Externí odkaz:
https://doaj.org/article/1c600edc63874da198b675b93d0594ea
Publikováno v:
BMC Neuroscience, Vol 25, Iss 1, Pp 1-14 (2024)
Abstract Background Microdosing psychedelics is a phenomenon with claimed cognitive benefits that are relatively untested clinically. Pre-clinically, psychedelics have demonstrated enhancing effects on neuroplasticity, which cannot be measured direct
Externí odkaz:
https://doaj.org/article/34a36cd186c64521aa7dc2d435256889
Autor:
Carina Joy Donegan, Dimitri Daldegan-Bueno, Rachael Sumner, David Menkes, William Evans, Nicholas Hoeh, Frederick Sundram, Lisa Reynolds, Rhys Ponton, Alana Cavadino, Todd Smith, Partha Roop, Nathan Allen, Binu Abeysinghe, Darren Svirskis, Anna Forsyth, Mahima Bansal, Suresh Muthukumaraswamy
Publikováno v:
Pilot and Feasibility Studies, Vol 9, Iss 1, Pp 1-16 (2023)
Abstract Background Globally, an estimated 260 million people suffer from depression [1], and there is a clear need for the development of new, alternative antidepressant therapies. In light of problems with the tolerability and efficacy of available
Externí odkaz:
https://doaj.org/article/b33c79e5717541308ff4e24bb008dcfa
Autor:
Julia R. Plank, Stephanie C. Glover, Ben D. Moloney, Nicholas R. Hoeh, Frederick Sundram, Rachael L. Sumner, Suresh Muthukumaraswamy, Joanne C. Lin
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background Major depressive disorder (MDD) is a leading cause of disability worldwide. The current treatments are ineffective in approximately one-third of patients, resulting in a large economic burden and reduced quality of life for a sign
Externí odkaz:
https://doaj.org/article/2e1c9e4d86f64eed9fc56b3fc5593ae7
Autor:
Hardik Rajpal, Pedro A.M. Mediano, Fernando E. Rosas, Christopher B. Timmermann, Stefan Brugger, Suresh Muthukumaraswamy, Anil K. Seth, Daniel Bor, Robin L. Carhart-Harris, Henrik J. Jensen
Publikováno v:
NeuroImage, Vol 263, Iss , Pp 119624- (2022)
Schizophrenia and states induced by certain psychotomimetic drugs may share some physiological and phenomenological properties, but they differ in fundamental ways: one is a crippling chronic mental disease, while the others are temporary, pharmacolo
Externí odkaz:
https://doaj.org/article/03bed7e686e14b25af31b994f94e526f
Autor:
Yun Zhao, Mario Boley, Andria Pelentritou, Philippa J. Karoly, Dean R. Freestone, Yueyang Liu, Suresh Muthukumaraswamy, William Woods, David Liley, Levin Kuhlmann
Publikováno v:
NeuroImage, Vol 263, Iss , Pp 119592- (2022)
Neural processes are complex and difficult to image. This paper presents a new space-time resolved brain imaging framework, called Neurophysiological Process Imaging (NPI), that identifies neurophysiological processes within cerebral cortex at the ma
Externí odkaz:
https://doaj.org/article/69436e75ed7d4345a7b664e1538b1c69
Autor:
Robin J. Murphy, Rachael L. Sumner, William Evans, David Menkes, Ingo Lambrecht, Rhys Ponton, Frederick Sundram, Nicholas Hoeh, Sanya Ram, Lisa Reynolds, Suresh Muthukumaraswamy
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-15 (2021)
Abstract Background Regular ingestion of sub-hallucinogenic doses of psychedelics, referred to as “microdosing”, has gained increasing popularity and attention in the press and in online forums, with reported benefits across multiple cognitive an
Externí odkaz:
https://doaj.org/article/121916c55efb4e23b3a6b4c665ecab07
Autor:
Joseph C. C. Chen, Rachael L. Sumner, Venkat Krishnamurthy Naga, Nicholas Hoeh, Hafis Adetokunbo Ayeni, Vikrant Singh, Frederick Sundram, Douglas Campbell, Suresh Muthukumaraswamy
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract Background Depressive disorders are a leading cause of disability, but current behavioural and pharmacological therapies have a slow onset of response, typically taking several weeks before achieving efficacy. Prior studies using triplicate
Externí odkaz:
https://doaj.org/article/7ec28ae5ea1448309a9bf7ee3ad51d41